Sathya Janardhanan
Venture Partner Ecphora Capital
Sathya Janardhanan is an accomplished biotech and venture capital expert. He previously served as VP of Development Manufacturing at Rise Therapeutics for over five years, overseeing CMC, manufacturing, and product development. He now consults for Rise, supporting their Phase 1/2 clinical programs and business expansion. As a Venture Partner, Sathya guides a Maryland-based VC firm into biotech, actively fostering a microbiome ecosystem in the D.C., Maryland, Virginia region by connecting companies with resources and investors. He also handles due diligence and investment decisions for Agfora Capital.
Seminars
Tuesday 10th November 2026
Panel Discussion: Positioning Microbiome Science & Clinical Translation to Meet Mainstream VC Investment Criteria Early
9:00 am
- Defining core investment checklists used by generalist biotech VCs to assess microbiome opportunities, enabling alignment of narratives with decision drivers
- Diagnosing causes of investor skepticism following early company failures to reposition data packages, risk profiles, and timelines for renewed confidence
- Attracting non-specialist venture investors by translating complex biology into clear value propositions and commercial milestones to expand the capital pool
